| Tretinoin | Approved Investigational Nutraceutical | ALDH7A1 | 501 |
downregulated | Tretinoin results in decreased expression of ALDH7A1 mRNA | 5q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ALDOC | 230 |
downregulated | Tretinoin results in decreased expression of ALDOC mRNA | 17q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ALDOC | 230 |
upregulated | Tretinoin results in increased expression of ALDOC mRNA | 17q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ALK | 238 |
downregulated | Tretinoin results in decreased expression of ALK mRNA | 2p23.2-p23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ALK | 238 |
upregulated | Tretinoin results in increased expression of ALK mRNA | 2p23.2-p23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ALKBH2 | 121642 |
downregulated | Tretinoin results in decreased expression of ALKBH2 mRNA | 12q24.11 | |
| Tretinoin | Approved Investigational Nutraceutical | ALMS1 | 7840 |
downregulated | Tretinoin results in decreased expression of ALMS1 mRNA | 2p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ALOX5 | 240 |
upregulated | Tretinoin results in increased expression of ALOX5 mRNA | 10q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | ALOX5AP | 241 |
upregulated | Tretinoin results in increased expression of ALOX5AP mRNA | 13q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ALPK2 | 115701 |
downregulated | Tretinoin results in decreased expression of ALPK2 mRNA | 18q21.31-q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | ALPL | 249 |
downregulated | Tretinoin results in decreased expression of ALPL mRNA | 1p36.12 | |
| Tretinoin | Approved Investigational Nutraceutical | ALPP | 250 |
downregulated | Tretinoin results in decreased expression of ALPP mRNA | 2q37.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ALX1 | 8092 |
upregulated | Tretinoin results in increased expression of ALX1 mRNA | 12q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | ALX3 | 257 |
upregulated | Tretinoin results in increased expression of ALX3 mRNA | 1p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AMD1 | 262 |
downregulated | Tretinoin results in decreased expression of AMD1 mRNA | 6q21 | |
| Tretinoin | Approved Investigational Nutraceutical | AMFR | 267 |
upregulated | Tretinoin results in increased expression of AMFR mRNA | 16q13 | |
| Tretinoin | Approved Investigational Nutraceutical | AMIGO2 | 347902 |
downregulated | Tretinoin results in decreased expression of AMIGO2 mRNA | 12q13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | AMMECR1L | 83607 |
upregulated | Tretinoin results in increased expression of AMMECR1L mRNA | 2q14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AMOTL1 | 154810 |
downregulated | Tretinoin results in decreased expression of AMOTL1 mRNA | 11q21 | |
| Tretinoin | Approved Investigational Nutraceutical | AMPH | 273 |
downregulated | Tretinoin results in decreased expression of AMPH mRNA | 7p14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ANAPC10 | 10393 |
downregulated | Tretinoin results in decreased expression of ANAPC10 mRNA | 4q31.21 | |
| Tretinoin | Approved Investigational Nutraceutical | ANAPC5 | 51433 |
upregulated | Tretinoin results in increased expression of ANAPC5 mRNA | 12q24.31 | |
| Tretinoin | Approved Investigational Nutraceutical | ANG | 283 |
upregulated | Tretinoin results in increased expression of ANG mRNA | 14q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ANGPT1 | 284 |
upregulated | Tretinoin results in increased expression of ANGPT1 mRNA | 8q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ANGPT2 | 285 |
upregulated | Tretinoin results in increased expression of ANGPT2 mRNA | 8p23.1 | |